Janus Henderson Group PLC Arvinas, Inc. Transaction History
Janus Henderson Group PLC
- $182 Billion
- Q2 2024
A detailed history of Janus Henderson Group PLC transactions in Arvinas, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 23,365 shares of ARVN stock, worth $598,144. This represents 0.0% of its overall portfolio holdings.
Number of Shares
23,365
Previous 32,429
27.95%
Holding current value
$598,144
Previous $1.34 Million
53.59%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding ARVN
# of Institutions
224Shares Held
68.7MCall Options Held
166KPut Options Held
31.3K-
Eco R1 Capital, LLC San Francisco, CA6.73MShares$172 Million6.33% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.67MShares$171 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.26MShares$160 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.99MShares$102 Million0.01% of portfolio
-
Avidity Partners Management LP Dallas, TX2.99MShares$76.5 Million3.91% of portfolio
About ARVINAS, INC.
- Ticker ARVN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,205,300
- Market Cap $1.36B
- Description
- Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...